SGT1B Antibody

What is SGT1B and what is its role in plant immunity?

SGT1B is a ubiquitin ligase-associated protein that plays a critical role in plant disease resistance. In Arabidopsis, SGT1B (along with its homolog SGT1A) is required for resistance responses mediated by nucleotide-binding site/leucine-rich repeat (NBS-LRR) proteins, which function as immune receptors in plants . SGT1B interacts with RAR1, another important component of plant immunity, and helps maintain the stability of R (resistance) proteins that recognize pathogen effectors .

SGT1B is specifically involved in effector-triggered immunity (ETI), where it supports the accumulation and function of R proteins. Interestingly, while SGT1B is essential for ETI, research has demonstrated that it is not required for bacterial PAMP-triggered immunity (PTI), suggesting a specialized role in specific immune signaling pathways . This selective involvement makes SGT1B an important marker for distinguishing between different immune response mechanisms in plants.

How do AtSGT1a and AtSGT1b differ functionally in Arabidopsis?

The key differences between these homologs lie in their expression patterns and protein stability rather than their intrinsic functions. The AtSGT1a promoter shows high induction during pathogen infection, allowing AtSGT1a to potentially reach sufficient levels to compensate for AtSGT1b deficiency in certain resistance responses . The N-terminal TPR domain influences differential protein accumulation: the TPR domain of AtSGT1a reduces steady-state levels of SGT1 proteins, while the same domain from AtSGT1b enhances SGT1 accumulation . This understanding is crucial when designing experiments using antibodies against either or both SGT1 variants.

What experimental techniques commonly employ SGT1B antibodies?

SGT1B antibodies are utilized in several key experimental techniques in plant immunity research:

• Western blotting: Used to quantify SGT1B protein levels during immune responses or in different genetic backgrounds.

• Co-immunoprecipitation (Co-IP): Essential for studying protein-protein interactions between SGT1B and other immunity components, such as RAR1, HSP90, and R proteins .

• Immunohistochemistry/Immunofluorescence: Used to visualize SGT1B localization in plant tissues during immune responses.

• Chromatin immunoprecipitation (ChIP): When studying transcriptional regulation related to SGT1B function.

• Protein stability assays: SGT1B antibodies help monitor the half-life and accumulation of resistance proteins in various genetic backgrounds .

For all these techniques, researchers should validate antibody specificity, particularly when working with species containing multiple SGT1 homologs.

How can SGT1B antibodies help differentiate between ETI and PTI signaling pathways?

SGT1B antibodies serve as powerful tools for distinguishing between ETI and PTI pathways due to SGT1B's selective involvement in ETI signaling. Research has demonstrated that SGT1B is required for ETI responses but not for PTI responses against bacterial pathogens . This differential requirement allows researchers to use SGT1B antibodies as specific markers for ETI pathway activation.

Methodologically, this differentiation can be accomplished through:

• Immunoprecipitation followed by mass spectrometry: Using SGT1B antibodies to pull down protein complexes during both ETI and PTI responses can reveal different interaction partners specific to each pathway. PTI-specific complexes would likely lack SGT1B or show weaker associations.

• Quantitative western blotting: Measuring SGT1B recruitment to protein complexes during ETI versus PTI can provide quantitative evidence of pathway-specific activation.

• Microscopy-based approaches: Using fluorescently labeled SGT1B antibodies to track subcellular relocalization during different immune responses can highlight ETI-specific dynamics.

These approaches allow researchers to definitively separate ETI from PTI responses in cases where phenotypic outcomes might otherwise be similar.

What are the key considerations for optimizing SGT1B immunoprecipitation protocols?

Successful immunoprecipitation of SGT1B requires careful optimization due to several factors:

• Antibody selection: Since SGT1 homologs share high sequence similarity, antibody specificity is critical. Consider using epitope-tagged SGT1B constructs when possible to enable use of highly specific commercial antibodies against the tag.

• Protein complex stability: SGT1B interactions with SKP1 have been described as weak or transient . To preserve these interactions:

  • Use gentle cell lysis methods

  • Include protein crosslinking steps (e.g., formaldehyde or DSP)

  • Optimize buffer conditions (salt concentration, detergent type/concentration)

  • Include protease inhibitors and phosphatase inhibitors

• Co-factor requirements: Some SGT1B interactions may depend on co-factors or post-translational modifications. Consider supplementing IP buffers with:

  • ATP (1-5 mM) for kinase-dependent interactions

  • Reducing agents (e.g., DTT) to preserve disulfide bonds

  • Appropriate divalent cations (e.g., Mg²⁺, Ca²⁺)

• Protein abundance optimization: SGT1B levels may vary depending on immune activation status. Time course experiments can identify optimal sampling points for capturing specific interactions.

• Controls: Include appropriate negative controls such as:

  • IgG control antibodies

  • Samples from sgt1b knockout plants

  • Competitive peptide blocking controls

These optimizations should be empirically determined for each experimental system and research question.

How can researchers address conflicting results when studying SGT1B's role across different plant species?

Conflicting results regarding SGT1B function across plant species are common due to several factors:

• Homolog diversity: Different plant species may have varying numbers of SGT1 homologs with different expression patterns and functional redundancy levels. For example, Arabidopsis has two homologs (AtSGT1a and AtSGT1b) that show functional redundancy , while other species may have different arrangements.

• Methodological approach to resolve conflicts:

  • Comprehensive homolog identification: Perform phylogenetic analyses to identify all SGT1 homologs within the study species before attributing functions.

  • Expression profiling: Quantify expression levels of all homologs under relevant conditions using RNA-seq or qRT-PCR.

  • Functional redundancy testing: Use CRISPR/Cas9 to generate single and multiple homolog knockouts to assess redundancy.

  • Specificity validation: Verify antibody specificity against each homolog using recombinant proteins or knockout lines.

• Cross-species complementation: To directly compare SGT1B function between species, perform cross-species complementation experiments where the SGT1B gene from one species is expressed in the sgt1b mutant of another species (e.g., expressing tomato SGT1B in Arabidopsis sgt1b mutants).

• Reconciling mechanistic differences: When conflicts persist, consider that SGT1B may have evolved species-specific functions or interaction networks. Use comparative interaction studies (e.g., IP-MS across species) to identify conserved and divergent SGT1B interactors.

By systematically addressing these factors, researchers can resolve apparent conflicts and gain deeper insights into SGT1B evolution and function.

What are the recommended approaches for quantifying SGT1B-dependent R protein accumulation?

Accurately quantifying SGT1B-dependent R protein accumulation is critical for understanding SGT1B's role in immunity. Recommended approaches include:

• Pulse-chase experiments:

  • Label newly synthesized proteins with radioactive amino acids or non-radioactive tags

  • Chase with unlabeled amino acids

  • Immunoprecipitate the R protein of interest at different time points

  • This approach reveals both synthesis rates and protein stability

• Cycloheximide chase assays:

  • Treat cells with cycloheximide to block new protein synthesis

  • Collect samples at different time points

  • Quantify R protein levels by western blotting

  • Calculate half-life of R proteins in wild-type versus sgt1b mutant backgrounds

• Quantitative western blotting optimization:

  • Use fluorescent secondary antibodies rather than chemiluminescence for wider linear range

  • Include internal loading controls (not housekeeping proteins that might be affected by immunity)

  • Generate standard curves using recombinant proteins

  • Ensure antibody concentrations are within the linear detection range

• Live-cell imaging approaches:

  • Generate fluorescently tagged R protein constructs

  • Monitor protein accumulation and turnover in real-time

  • Compare dynamics in SGT1B-silenced versus control plants

For example, studies have shown that silencing NbSGT1 in Nicotiana benthamiana reduces steady-state levels of the Rx resistance protein, demonstrating SGT1's role in maintaining stability of preactivated R proteins . The recommended quantification approaches can help distinguish between effects on protein synthesis, folding, and degradation.

How can SGT1B antibodies be used in multiplexed immunostaining without cross-reactivity?

Multiplexed immunostaining with SGT1B antibodies presents challenges, particularly when using multiple primary antibodies raised in the same species. To minimize cross-reactivity:

• Pre-labeling strategy with secondary nanobodies (2.Nbs):

  • Pre-incubate each primary antibody (including anti-SGT1B) with fluorescently labeled secondary nanobodies specific to the host species

  • Optimize the 2.Nb excess to ensure saturation (typically 20-25% excess beyond available binding sites)

  • Use protein LoBind tubes with primary antibodies diluted to 10-30 nM

  • Incubate for one hour at room temperature prior to staining

• Validation of staining specificity:

  • Perform single-antigen controls alongside multiplexed experiments

  • Quantitatively compare signal distribution between single and multiplexed conditions

  • Assess potential cross-over at the single-molecule level using TIRF microscopy

• Sequential staining approach:

  • Apply the first primary antibody and detect with a directly conjugated secondary antibody

  • Block remaining epitopes on the first primary antibody

  • Apply subsequent primary antibodies and their corresponding detection reagents

• Antibody fragment approaches:

  • Generate Fab fragments of SGT1B antibodies

  • Directly label these fragments with bright, photostable fluorophores

  • Use size exclusion chromatography to remove unbound fluorophores

When properly optimized, these methods minimize cross-reactivity. Research has shown that well-optimized nanobody-based approaches result in negligible off-target binding (<2%) in multiplex assays , making them suitable for quantitative co-localization studies of SGT1B with its interacting partners.

How does the TPR domain influence SGT1B antibody selection and experimental design?

The TPR domain of SGT1B significantly affects protein stability and potentially epitope accessibility, warranting careful consideration in antibody selection and experimental design:

• Antibody targeting considerations:

  • The TPR domain of AtSGT1b enhances protein accumulation, while the same domain from AtSGT1a reduces steady-state levels

  • Antibodies targeting epitopes within or near the TPR domain may exhibit differential accessibility depending on protein conformation or interaction state

  • When possible, use antibodies targeting conserved regions outside the TPR domain for consistent detection across homologs

• Experimental design implications:

  • For comparative studies across SGT1 homologs, normalize data to account for TPR-dependent stability differences

  • Consider using multiple antibodies targeting different SGT1B domains to confirm results

  • When studying SGT1B interactions mediated by the TPR domain, epitope masking may occur, necessitating alternative detection approaches

• Recommended approach for functional studies:

  • Generate domain-swap constructs between SGT1A and SGT1B TPR domains

  • Create point mutations at critical residues (e.g., positions 91 and 100 in Arabidopsis SGT1) to modulate protein stability

  • Use antibodies recognizing shared epitopes to compare accumulation and function

• Technical validation approach:

  • Express recombinant SGT1B proteins with and without the TPR domain

  • Test antibody reactivity against both variants by western blotting

  • Quantify detection efficiency to identify potential biases

Understanding these TPR domain effects is crucial for accurate interpretation of results, particularly when comparing SGT1B levels or functions across different experimental conditions or genetic backgrounds.

What controls are essential when using SGT1B antibodies in various experimental systems?

Robust experimental design with SGT1B antibodies requires comprehensive controls:

• Antibody specificity controls:

  • Knockout/knockdown validation: Include sgt1b mutant or SGT1B-silenced samples to confirm signal specificity

  • Peptide competition: Pre-incubate antibody with immunizing peptide to block specific binding

  • Recombinant protein standards: Include purified SGT1B protein as positive control

  • Cross-reactivity assessment: Test antibody against related proteins (e.g., SGT1A) to determine specificity

• Experimental controls by technique:

  Technique	Essential Controls	Rationale
  Western blot	Loading controls (non-immunity related)	Ensures signal differences reflect SGT1B changes, not loading variation
  	Signal linearity validation	Confirms quantitation occurs within linear detection range
  Immunoprecipitation	IgG control	Identifies non-specific binding
  	Input samples	Verifies starting material composition
  	Unrelated protein IP	Controls for technique-specific artifacts
  Immunofluorescence	Secondary antibody only	Detects non-specific secondary binding
  	Blocking peptide	Confirms primary antibody specificity
  	Untreated samples	Establishes baseline expression

• Biological validation controls:

  • Include known conditions that alter SGT1B expression or function (e.g., pathogen treatment)

  • Compare results across multiple plant accessions or species

  • Use alternative detection methods to confirm key findings

Implementing these controls enables confident interpretation of results and facilitates troubleshooting when unexpected outcomes occur.

How should experimental design address functional redundancy between SGT1 homologs?

Addressing functional redundancy between SGT1 homologs requires systematic experimental approaches:

• Gene expression profiling strategy:

  • Perform RT-qPCR or RNA-seq to quantify expression levels of all SGT1 homologs

  • Compare expression patterns across tissues, developmental stages, and responses to different pathogens

  • Identify conditions where one homolog predominates or where expression patterns diverge

• Genetic manipulation approaches:

  • Generate single, double, and higher-order mutants of SGT1 homologs

  • Create dosage series by combining knockout and knockdown approaches

  • Design complementation constructs with homolog-specific promoters and coding sequences

• Protein-level analysis:

  • Use homolog-specific antibodies where possible

  • For shared epitopes, combine immunological detection with genetic backgrounds lacking specific homologs

  • Assess post-translational modifications that might differ between homologs

• Domain swap experiments:

  • Create chimeric proteins containing domains from different SGT1 homologs

  • Express these under native promoters in appropriate mutant backgrounds

  • For example, swap the TPR domains between AtSGT1a and AtSGT1b to assess their effect on protein stability and function

• Comparative interaction studies:

  • Perform immunoprecipitation followed by mass spectrometry for each homolog

  • Identify unique and shared interaction partners

  • Quantify interaction strengths under different conditions

This systematic approach has revealed that in Arabidopsis, while genetic screens initially identified only AtSGT1b as required for resistance, both AtSGT1a and AtSGT1b can mediate resistance in a dose-dependent manner, with functional redundancy between the two proteins .

What troubleshooting strategies help resolve inconsistent SGT1B antibody performance?

Inconsistent SGT1B antibody performance can stem from multiple factors. Here's a systematic troubleshooting approach:

• Antibody storage and handling:

  • Avoid repeated freeze-thaw cycles (aliquot antibodies upon receipt)

  • Store according to manufacturer recommendations (typically -20°C or -80°C)

  • Use proper non-contaminating tubes (protein LoBind recommended)

  • Centrifuge antibody solution before use to remove aggregates

• Sample preparation optimization:

  • Protein extraction method: Compare different extraction buffers and methods

  • Protease inhibitors: Ensure complete protease inhibitor cocktails are fresh and active

  • Denaturing conditions: Adjust SDS concentration and heating time/temperature

  • Reducing agents: Optimize DTT or β-mercaptoethanol concentration

• Technique-specific troubleshooting:

  Issue	Potential Causes	Solutions
  Weak western blot signal	Insufficient protein	Increase loading amount
  	Inefficient transfer	Optimize transfer conditions for SGT1B's molecular weight
  	Antibody concentration	Titrate primary and secondary antibodies
  High background	Non-specific binding	Increase blocking time/concentration
  	Secondary antibody issues	Use highly cross-adsorbed secondaries
  	Buffer contaminants	Prepare fresh buffers
  IP failure	Epitope inaccessibility	Try different lysis conditions
  	Weak/transient interactions	Use crosslinking approaches
  	Suboptimal antibody:bead ratio	Titrate antibody amount for IP

• Validation approaches:

  • Test antibody on recombinant SGT1B protein

  • Compare performance across different plant species or tissues

  • Consider testing multiple antibodies targeting different SGT1B epitopes

• Specialized solutions for challenging applications:

  • For detecting low-abundance SGT1B, consider signal amplification systems

  • For distinguishing closely related homologs, use competition assays with specific peptides

  • For co-localization studies, optimize pre-labeling with secondary nanobodies

Implementing these troubleshooting strategies systematically will help identify and resolve the specific factors affecting antibody performance in your experimental system.

How can researchers interpret SGT1B-related results in the context of pathogen specificity?

Interpreting SGT1B-related results across different pathosystems requires careful consideration:

When interpreting results, consider that while SGT1 is required for resistance mediated by both TIR-NBS-LRR and CC-NBS-LRR proteins , its precise role may differ between these pathways and across plant species, necessitating careful comparative analysis.

What approaches are recommended for studying post-translational modifications of SGT1B?

Studying post-translational modifications (PTMs) of SGT1B requires specialized approaches:

• PTM detection strategies:

  • Phosphorylation: Use phospho-specific antibodies or Phos-tag SDS-PAGE

  • Ubiquitination: Perform immunoprecipitation under denaturing conditions followed by ubiquitin-specific western blotting

  • SUMOylation: Use SUMO-specific antibodies following immunoprecipitation

  • Glycosylation: Apply glycosidase treatments combined with mobility shift analysis

• Mass spectrometry approaches:

  • Sample preparation: Enrich for SGT1B using immunoprecipitation

  • PTM enrichment: Use TiO₂ for phosphopeptides or specific PTM-binding domains

  • MS analysis: Perform both discovery mode and targeted MRM for specific modifications

  • Data analysis: Use PTM-specific search algorithms and spectral validation

• Functional analysis of PTMs:

  • Generate phosphomimetic and phospho-null mutations at identified sites

  • Express these variants in sgt1b mutant backgrounds

  • Assess impact on SGT1B stability, localization, and interaction partners

  • Evaluate effects on disease resistance phenotypes

• Dynamics of PTMs during immune responses:

  • Design time-course experiments following pathogen challenge

  • Compare PTM patterns between compatible and incompatible interactions

  • Correlate PTM changes with SGT1B activity in R protein stabilization

• PTM crosstalk analysis:

  • Investigate interdependence between different PTMs

  • Assess sequential modification patterns

  • Identify enzymes responsible for adding/removing modifications

These approaches enable comprehensive characterization of SGT1B's post-translational regulation during immune responses and provide mechanistic insights into how its activity is modulated in different contexts.

What cutting-edge methodologies are advancing SGT1B antibody applications in plant immunity research?

Recent technological advances have expanded SGT1B antibody applications in plant immunity research:

• Single-molecule imaging techniques:

  • Single-molecule pull-down (SiMPull): Allows visualization of individual SGT1B-containing protein complexes

  • Single-molecule FRET: Measures nanoscale conformational changes in SGT1B during immune activation

  • TIRFM with pre-labeled antibodies: Enables highly specific multiplexed imaging with minimal cross-reactivity

• Spatial proteomics approaches:

  • Proximity labeling: Using SGT1B fused to enzymes like TurboID or APEX2 to identify proximity interactors

  • FACS-based organelle proteomics: Tracking SGT1B distribution across subcellular compartments during immune responses

  • In situ proximity ligation assay (PLA): Visualizing SGT1B interactions with R proteins in native cellular contexts

• Nanobody-based innovations:

  • Intrabodies: Expression of anti-SGT1B nanobodies inside cells to track or modulate function

  • Bi-specific nanobodies: Linking SGT1B to specific subcellular locations or protein partners

  • Pre-labeling strategies: Optimized protocols for multiplexed detection without cross-reactivity issues

• Advanced protein dynamics tracking:

  • Real-time biosensors: FRET-based sensors to monitor SGT1B conformational changes

  • Optogenetic tools: Light-controlled SGT1B activity to dissect temporal requirements

  • CRISPR-based tagging: Endogenous labeling of SGT1B for native expression level studies

• Systems-level analysis:

  • Spatial transcriptomics: Correlating SGT1B protein patterns with gene expression landscapes

  • Multi-omics integration: Combining SGT1B antibody-based studies with transcriptomics, metabolomics, and phenomics

  • Network analysis: Positioning SGT1B within dynamic protein interaction networks during immune responses

These cutting-edge methods provide unprecedented resolution into SGT1B function and may resolve longstanding questions about its mechanistic roles in plant immunity.

How should researchers address species-specific differences when using SGT1B antibodies?

When using SGT1B antibodies across different plant species, researchers must address several species-specific considerations:

• Epitope conservation analysis:

  • Perform sequence alignments of SGT1B across target species

  • Identify conserved and variable regions that might affect antibody binding

  • Select antibodies targeting highly conserved epitopes for cross-species applications

  • Consider generating species-specific antibodies for divergent regions

• Validation strategy for cross-species applications:

  • Test antibody reactivity against recombinant SGT1B from each species

  • Perform western blots on samples from multiple species in parallel

  • Include genetic controls (knockout/knockdown) for each species when possible

  • Quantify relative detection efficiency to enable accurate cross-species comparisons

• Data normalization approaches:

  • Use different SGT1B concentrations to establish species-specific standard curves

  • Adjust for different SGT1B homolog numbers across species

  • Account for species-specific expression patterns and regulation

  • Consider cellular abundance differences when interpreting co-localization data

• Technical adaptations for different plant species:

  • Optimize protein extraction protocols for species-specific tissues

  • Adjust immunoprecipitation conditions based on cellular composition

  • Modify fixation procedures for immunohistochemistry based on tissue characteristics

  • Adapt blocking reagents to minimize species-specific background

• Species-specific interaction network considerations:

  • SGT1B may interact with different R protein repertoires across species

  • Functional redundancy between SGT1 homologs may vary by species

  • Regulatory mechanisms may differ, affecting experimental interpretation

These approaches help ensure accurate interpretation of SGT1B antibody-based results across different plant species, facilitating comparative studies of plant immune mechanisms.